Clinical trial Recruiting at 1 site Observational Ages 18 and up

Adults' views of childhood toxin injections for cerebral palsy

Official title: How Do Adults With Cerebral Palsy Perceive Their Botulinum Toxin Treatment During Childhood ?

Run by Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française · NCT07377201 · Data updated 2026-11-12

This survey asks adults with cerebral palsy who had repeated botulinum toxin injections as children to report how those treatments affected them long term.

More Cerebral Palsy (CP) trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorCentre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française
Academic / other
Locations1 site (Lyon)
StatusRecruiting
StartedFebruary 1, 2026
Main results expectedAugust 1, 2027
Study endsAugust 1, 2027
Registry record updatedSeptember 9, 2026
Trial IDNCT07377201 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age ≥18) with a diagnosis of cerebral palsy who received more than two series of botulinum toxin injections during childhood and can complete the questionnaire are ideal candidates.

Probably not a fit

People who never had repeated childhood toxin injections or who cannot complete the questionnaire or provide the required confirmation information are unlikely to benefit from this survey.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project uses a patient-reported questionnaire to collect adult perspectives on repeated childhood botulinum toxin injections and other pediatric interventions for cerebral palsy. Eligible participants are 18 or older, have a CP diagnosis, received more than two series of toxin injections in childhood, and can complete the survey (with assistance if needed). The questionnaire captures functional, emotional, and satisfaction-related outcomes across all GMFCS levels. Results aim to fill gaps in long-term, patient-centered outcome data to inform future care decisions.

Why it matters

Potential benefit: If successful, the survey could clarify how childhood toxin injections influence long-term satisfaction and quality of life, helping clinicians align pediatric spasticity care with patient values.

How similar studies have gone: Some prior research has examined long-term clinical outcomes of botulinum toxin in CP, but long-term patient-reported perspectives on repeated childhood injections remain limited, making this survey relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants aged 18 years or older
* Diagnosed with cerebral palsy
* Received repeated toxin injections during childhood (\> 2 series of injections)
* Agreeing to complete the questionnaire
* Possessing sufficient cognitive abilities, particularly in terms of reading comprehension and oral comprehension (even if someone had to physically assist them in responding)
* All levels of the GMFCS classification 1 to 5

Exclusion Criteria:

* Individuals who do not meet the above criteria, as confirmed by the statements in Part 1 of the survey, will be automatically excluded from the study.

Where it's running

  • CMCR des Massues
    Lyon, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.